Epaper हिन्दी
Breaking News
Feature

Study finds delaying harsh treatments for prostate cancer does not increase death risk

On
Study finds delaying harsh treatments for prostate cancer does not increase death risk

According to a long-term study published in the New England Journal of Medicine, most men diagnosed with prostate cancer can delay or avoid harsh treatments without harming their chances of survival.

The study evaluated three major treatment options: active monitoring, surgery, and radiotherapy with hormones for 1,643 men aged 50-69 years across the UK with localised prostate cancer.

The study showed that active monitoring of prostate cancer had the same high survival rates after 15 years as radiotherapy or surgery, and negative impacts of radiotherapy and surgery on urinary and sexual function persist for up to 12 years.

The study suggests that active monitoring by healthcare professionals could be an equally valid and less harsh option.

Follow Us On Follow Us on Google NEws
Tags: Health

Related Posts